The government has earmarked Rs 5,000 crore in the next fiscal just for Covid vaccination of 15-17-year-age group and precautionary dose for senior citizens, Finance Secretary T V Somanathan said, emphasising more money will be allocated as needs arise.
The government in the last Budget had provisioned Rs 35,000 crore towards Covid vaccination for the 2021-22 fiscal. The amount has been upped to Rs 39,000 crore in the revised estimates.
Asked about the reason for reduced outlay for 2022-23 fiscal, Somanathan explained that while the outlay in the last budget was towards vaccinating full adult population, the next fiscal's allocation needs to be seen in the context of 'precautionary doses' and jabs to children in the age group of 15-17 years.
"Last year the provision was for two doses of vaccination for 100 per cent of adult population. The allocations are made based on the evolving health policy. Currently the health policy is booster for certain segments -- frontline, above 60 years and vaccination for 15-17 years. That amount has been catered to. Rs 5,000 crore has been earmarked," he told PTI.
The nationwide COVID-19 vaccination drive started on January 16, 2021. The new phase of universalisation of COVID-19 vaccination commenced from June 21, 2021. As part of the nationwide vaccination drive, the Government of India has been supporting the states and UTs by providing them COVID vaccines free of cost.
Over 75 per cent of the country's adult population is now fully vaccinated against COVID-19. More than 164.36 crore vaccine doses have been provided to states and Union Territories as a part of the nationwide COVID-19 vaccination drive.
Vaccination for children of 15-17-age group has begun from January 3, while 'precautionary dose' for 60 years and above began from January 10.
Somanathan further said: "As policies are evolved, the budgets will follow. But Budget will not precede the policy".
The secretary said there has been an increase in health outlay for next fiscal to Rs 83,000 crore. In the current fiscal, Rs 82,921 crore has been pegged in the Revised Estimates (RE), up from and Rs 71,269 crore in the Budget Estimates.
Also expenditure on health research too has seen an increase to Rs 3,201 crore in the next fiscal, from Rs 3,080 crore in the RE of current fiscal.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)